Swiss Lions 100 | 2026 edition
Alcon
Alcon is No. 64 in the Swiss Lions 100 and No. 8 in Life Sciences & Health, with a score of 45.3 out of 100. Headquarters: Geneva, canton of Geneva.
- Swiss Lions score
- 45.3
- Overall rank
- 64of 100
- Life Sciences & Health
- 8of 14
About
Eye care company making surgical equipment, contact lenses and eye drops. It is headquartered in Geneva and was spun off from Novartis in 2019.
How the score is made
Global scale
CHF 7.3bn revenue.
Swiss value
Swiss made: Limited.
Prominence
Online attention across languages, and worldwide search interest.
Impact
No current SBTi target. Not a certified B Corp.
Philanthropy
None found.
Key figures
- Revenue used in the ranking
- CHF 7.3bnTTM Oct 2026, company
- Revenue
- USD 10.9bnTwelve months to 30 June 2026
- Net profit
- USD 643mAttributable to shareholders
- Dividends paid
- USD 174mTo all shareholders
- Employees worldwide
- 25,000
Employees in Switzerland and dividends paid to Swiss shareholders are not published consistently, so they are not shown.
Profile
- Headquarters
- GenevaCanton of Geneva
- Language region
- French-speaking
- Category
- Life Sciences & Health
- Ownership
- Listed
- Main customers
- Consumers and businesses
- Chief executive
- David J. EndicottSince 2019. Source
- Founded
- 1945
Nearby in the Swiss Lions 100
Also in Life Sciences & Health
1RocheScore 80.8
2NovartisScore 78.6
3LonzaScore 59.5
4SonovaScore 54.8
5SandozScore 54.5
6StraumannScore 53.5
See all 14 brands in Life Sciences & Health.
Sources
- Revenue used in the ranking: stockanalysis.com ALC (TTM Oct 2026).
- Revenue, net profit, dividends and employees: stockanalysis.com, from company filings.
- Climate target: Science Based Targets initiative dashboard, October 2026. Foundations: Swiss commercial register. B Corp: B Lab directory.
Something out of date?
If a figure is wrong, or Alcon can publish figures for the next edition, tell us. Corrections are recorded with their source.